NCT03841539

Brief Summary

By doing this study, researchers hope to learn how the Mediterranean and low-fat eating patterns affect memory, brain volume, brain antioxidant status and cardio-metabolic biomarkers, such as blood pressure and blood glucose, in cognitively normal older adults. Researchers also plan to examine underlying processes relating the patterns to brain health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
209

participants targeted

Target at P75+ for not_applicable alzheimer-disease

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

March 7, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2023

Completed
Last Updated

June 7, 2024

Status Verified

June 1, 2024

Enrollment Period

4 years

First QC Date

January 18, 2019

Last Update Submit

June 5, 2024

Conditions

Keywords

Cognitive ImpairmentDementiaAlzheimer DiseaseMediterranean DietLow Fat Diet

Outcome Measures

Primary Outcomes (1)

  • Change in a composite global cognition score

    Alzheimer's Disease Cooperative Study-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) and NIH Toolbox (NIH-TB) Cognition Battery and will be used to assess changes in a composite global cognition score at baseline, 6, and 12 months.

    Baseline, 6 months and 12 months

Secondary Outcomes (29)

  • Change in Verbal Memory Factor

    Baseline, 6 months and 12 months

  • Change in Visuospatial Processing Factor

    Baseline, 6 months and 12 months

  • Change in Attention Factor

    Baseline, 6 months and 12 months

  • Change in Executive Function Factor

    Baseline, 6 months and 12 months

  • Change in Speed of Processing Factor

    Baseline, 6 months and 12 months

  • +24 more secondary outcomes

Study Arms (2)

Mediterranean Diet

EXPERIMENTAL

Follow a Mediterranean eating pattern and take a study supplement for one year. Dietary education will be provided by a Registered Dietitian.

Behavioral: Mediterranean DietDietary Supplement: Study Supplement

Low-fat Diet

ACTIVE COMPARATOR

Follow a low-fat eating pattern and take a study supplement for one year. Dietary education will be provided by a Registered Dietitian.

Dietary Supplement: Study SupplementBehavioral: Low-fat Diet

Interventions

Diet consisting of fruits, vegetables, whole grains, low-fat dairy, olive oil, seafood, nuts and beans. It is low in red and processed meats, solid fats and added sugars.

Mediterranean Diet
Study SupplementDIETARY_SUPPLEMENT

Randomized to take a daily dose of either 2 grams of Omega 3 fatty acids or 2 grams of a Placebo.

Low-fat DietMediterranean Diet
Low-fat DietBEHAVIORAL

Diet consisting of fruits, vegetables, whole grains, low-fat dairy, and low-fat protein, with fat contributing no more than 25% of calories.

Low-fat Diet

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Cognitively normal older adults ≥65 years (MMSE score ≥ 25; AD8 score of 2 or less; no prior diagnosis of MCI, AD or dementia; and not medically treated for cognitive impairment or dementia)
  • Speak English as a primary language
  • Be able to read and write in English
  • Live in the Kansas City, Metropolitan area
  • Body Mass Index (BMI) range between 20 - 40 kg/m2

You may not qualify if:

  • Serious medical risk, such as type 1 diabetes mellitus, cancer, recent cardiac event (e.g. heart attach, angioplasty)
  • Taking the prescription drug Warfarin
  • Taking a prescription fish oil, such as Lovaza, Omtryga, Vascepa, Epanova, etc., or prescribed a dose of over-the-counter (OTC) fish oil containing ≥300 mg Docohexanoic Acid (DHA) that cannot be adjusted to a lower dose
  • Nut allergy, fish allergy (does not include shellfish)
  • Adherence to specialized diet regimes (e.g., vegan, bariatric, renal, etc.) that make following either of the dietary plans impossible or unsafe
  • Unwilling to be randomized to one of two diet interventions
  • Evidence of severe major depression (GDS-SF ≥9) or presence of a major psychiatric disorder that in the investigator's opinion, could interfere with adherence to research assessments or procedures
  • Alcohol (over 3 drinks per day or total of 18 per week) or drug abuse, defined as the use of chemical substances (prescription, OTC or illegal drugs) in a pattern that can lead to an increased risk of problems and an inability to control the use of the substance
  • Do not have access to or independence over grocery shopping and meal preparation (i.e. those in military, retirement community with reliance on dining facilities for meals)
  • Already consuming a Mediterranean diet as determined using the 14-item MedD Assessment Tool (score of ≥8)
  • Already consuming a low-fat diet as determined by the NCI Percentage Energy from Fat Screener (≤ 15% of calories from fat)
  • Already participating in another research study
  • Another member of household is already participating in this study
  • Have a visual impairment that greatly diminishes ability to read or write
  • Currently attempting to lose weight

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Conditions

Alzheimer DiseaseCognitive DysfunctionDementia

Interventions

Diet, MediterraneanDiet, Fat-Restricted

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Debra K Sullivan, PhD, RD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Raters - (psychometrician, brain magnetic resonance imaging (MRI), dual energy x-ray absorptiometry (DEXA), and phlebotomy) will be blinded to the intervention group and will perform outcome assessments.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomized to a dietary intervention; Mediterranean or Low-Fat, and will follow this eating pattern for 12 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair and Endowed Professor of Clinical Nutrition

Study Record Dates

First Submitted

January 18, 2019

First Posted

February 15, 2019

Study Start

March 7, 2019

Primary Completion

March 15, 2023

Study Completion

March 22, 2023

Last Updated

June 7, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations